Zealand’s Dual GLP-1/GLP-2 Agonist Shows Modest Weight Loss at Low Doses
Biotech company Zealand Pharma reported early clinical trial results for their experimental drug ZP2929, a dual agonist targeting both the…
Empowering Your Journey to a Healthier You
Wellness Accelerator
